| Active ingredient (INN) | Isoniazid |
|---|---|
| ATC level 5 | J04AC01 |
| ATC level 4 | J04AC |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | ALLIANCE PHARMACEUTICALS LIMITED, MORNINGSIDE HEALTHCARE LIMITED, DAWA LIMITED, MACLEODS PHARMA UK LIMITED +4 more |
| Registrations on file | 11 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| ISONIAZID 50 MG/2 ML SOLUTION FOR INJECTION | 50 MG | injection | 🇬🇧 GB | ALLIANCE PHARMACEUTICALS LIMITED | Active |
| ISONIAZID 100MG TABLETS | 100MG | tablet | 🇬🇧 GB | MORNINGSIDE HEALTHCARE LIMITED | Active |
| ISONIAZID 50MG TABLETS | 50MG | tablet | 🇬🇧 GB | DAWA LIMITED | Active |
| ISONIAZID 100 MG TABLETS | 100 MG | tablet | 🇬🇧 GB | MACLEODS PHARMA UK LIMITED | Active |
| Isoniazid Tablets Bp | 50MG | tablet | 🇬🇧 GB | RPH PHARMACEUTICALS AB | Active |
| Isoniazid Tablets Bp | 100MG | tablet | 🇬🇧 GB | RPH PHARMACEUTICALS AB | Active |
| ISONIAZID 100mg tablet bottle | 100mg | — | 🇦🇺 AU | — | Active |
| Isoniazid | 100mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Discontinued |
| Isoniazid | 300mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Discontinued |
| Isoniazid | 100mg/mL | injection | 🇺🇸 US | SANDOZ INC | Active |
| Isoniazid | 50mg/5mL | solution | 🇺🇸 US | CMP Pharma, Inc. | Active |